Below are the financial statements of IPCA Laboratories, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of INR | 2025 | 2024 |
|---|---|---|
| Non-current assets | — | — |
| Property, plant & equipment | 38,504.9b | 41,233b |
| Capital work-in-progress | 6,161.7b | 3,235.9b |
| Goodwill on consolidation | 828.1b | 828.1b |
| Goodwill on acquisition | 77.7b | 77.7b |
| Other intangible assets | 1,070.6b | 1,233b |
| Intangible assets under development | 56b | 193b |
| Right of use assets | 2,184.2b | 2,162.1b |
| Biological assets other than bearer plant | 2.6b | 1.4b |
| Investment accounted for using the equity method | 1,910b | 1,570.2b |
| Financial assets | — | — |
| Investments | 253.2b | 1,465.9b |
| Loans | 323.5b | 885.9b |
| Others | 998.9b | 859.3b |
| Deferred tax assets (net) | 169.2b | 42.3b |
| Other non-current assets | 2,379.5b | 1,836b |
| Total non-current assets | 54,920.1b | 55,623.8b |
| Current assets | — | — |
| Inventories | 25,604.2b | 24,713.1b |
| Financial assets | — | — |
| Investments | 7,633.9b | 5,584b |
| Trade receivables | 18,738.2b | 16,865.1b |
| Cash and cash equivalents | 1,671.7b | 2,089.1b |
| Bank balances other than | 1,770.6b | 879.3b |
| Loans | 427.6b | 94b |
| Others | 385b | 767.3b |
| Current tax assets (net) | 0b | 0b |
| Other current assets | 3,439.2b | 4,363.6b |
| Total current assets | 59,670.4b | 55,355.5b |
| Non current assets classified as held for sale | 3,015b | 33.5b |
| Total assets | 117,605.5b | 111,012.8b |
| Equity | — | — |
| Equity share capital | 253.7b | 253.7b |
| Other equity | 69,230.8b | 63,068.2b |
| Equity attributable to owners of the holding company | 69,484.5b | 63,321.9b |
| Non-controlling interest | 14,398.2b | 13,948.1b |
| Total equity | 83,882.7b | 77,270b |
| Financial liabilities | — | — |
| Borrowings | 5,432.4b | 5,804.1b |
| Lease liability | 509b | 399.3b |
| Other financial liabilities | 0b | 0b |
| Non-current liabilities | — | — |
| Provisions | 963.1b | 868.4b |
| Deferred tax liabilities (net) | 2,949.7b | 3,104.7b |
| Other non-current liabilities | 6.4b | 9.9b |
| Total non-current liabilities | 9,860.6b | 10,186.4b |
| Financial liabilities | — | — |
| Borrowings | 7,584.6b | 8,070.9b |
| Lease liability | 101.4b | 109.3b |
| Trade payables | — | — |
| Dues of micro & small enterprises | 991.7b | 708.4b |
| Dues of others | 7,470b | 7,052.4b |
| Other financial liabilities | 3,653.2b | 3,516.1b |
| Current liabilities | — | — |
| Provisions | 2,691.7b | 2,445.6b |
| Other current liabilities | 867.8b | 1,222.3b |
| Current tax liabilities (net) | 482.5b | 431.4b |
| Liabilities associated with non current assets held for sale | 19.3b | 0b |
| Total current liabilities | 23,862.2b | 23,556.4b |
| Total equity and liabilities | 117,605.5b | 111,012.8b |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore IPCA Laboratories’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.